|
Milprazon 4 mg/10 mg
|
-
|
V/DCP/15/0009
|
KRKA, d.d., Novo mesto, Slovēnija
|
QP54AB51
|
small cats; kittens weighing at least 0.5 kg
|
Vairāk
|
Medicinal product information
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| V/DCP/15/0009-01 |
|
1 |
Al/OPA/Al/PVH blisteris, 2 tablete |
[JPG]
[JPG]
|
| V/DCP/15/0009-02 |
|
1 |
Al/OPA/Al/PVH blisteris, 4 tablete |
[PDF]
|
| V/DCP/15/0009-03 |
|
12 |
Al/OPA/Al/PVH blisteris, 4 tablete |
[PDF]
|
|
|
Forthyron flavour
|
800 µg/tabl.
|
V/MRP/18/0052
|
Eurovet Animal Health B.V., Nīderlande
|
QH03AA01
|
dogs
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
tablets
|
| International name (active substance): |
Levothyroxine sodium
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
Eurovet Animal Health B.V., Nīderlande;Dales Pharmaceuticals Ltd., Lielbritānija;GENERA Inc., Horvātija
|
| Date of authorisation/renewal: |
28-Jan-2022
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
MRP
|
| Package leaflet: |
[DOCX] 260122LI (26-Jan-2022)
|
| Labelling text: |
[DOCX] 20112020M (20-Nov-2020)
|
| Summary of product characteristics: |
[DOCX] 20112020ZA (20-Nov-2020)
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| V/MRP/18/0052-01 |
|
50 |
alumīnija/PVC/PE/PVDC blisteris, 10 tablete |
[PDF]
|
| V/MRP/18/0052-02 |
|
250 |
alumīnija/PVC/PE/PVDC blisteris, 10 tablete |
[PDF]
[PDF]
|
|
|
LV Intrafer-200 B12
|
-
|
V/NRP/20/0034
|
Interchemie Werken De Adelaar Eesti AS, Igaunija
|
QB03AE
|
cattle; pigs; dogs
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
solution for injection
|
| International name (active substance): |
Iron(III)-hydroxide dextran complex, Cyanocobalamin
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
Interchemie Werken De Adelaar Eesti AS, Igaunija
|
| Date of authorisation/renewal: |
28-Jan-2022
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
NRP
|
| Package leaflet: |
[DOCX] 30062020LI (30-Jun-2020)
|
| Labelling text: |
[DOCX] 30062020M (30-Jun-2020)
|
| Summary of product characteristics: |
[DOCX] 30062020ZA (30-Jun-2020)
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| V/NRP/20/0034-01 |
|
1 |
Stikla flakons, 100 ml |
-
|
|
|
LV Biocillin-200 WS
|
200 mg/g
|
V/NRP/11/0064
|
Interchemie Werken De Adelaar Eesti AS, Igaunija
|
QJ01CA04
|
poultry; pigs
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
powder for oral solution
|
| International name (active substance): |
Amoxicillin trihydrate
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
Interchemie Werken De Adelaar Eesti AS, Igaunija
|
| Date of authorisation/renewal: |
30-Nov-2016
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
NRP
|
| Package leaflet: |
[PDF] 281116LI (30-Nov-2016)
|
| Labelling text: |
[PDF] 281116M (30-Nov-2016)
|
| Summary of product characteristics: |
[PDF] 281116ZA (30-Nov-2016)
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| V/NRP/11/0064-01 |
200 mg/g |
1 |
ABPE trauciņš, 1000 g |
[JPG]
|
|
|
Tialin
|
250 mg/ml
|
V/DCP/18/0032
|
Dechra Regulatory B.V., Nīderlande
|
QJ01XQ01
|
pigs; turkeys; chickens
|
Vairāk
|
Medicinal product information
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| V/DCP/18/0032-01 |
|
1 |
ABPE pudele, 1 l |
-
|
| V/DCP/18/0032-02 |
|
1 |
Polietilēna konteiners, 5 l |
-
|
|
|
Prednicortone vet
|
20 mg
|
V/DCP/15/0025
|
Dechra Regulatory B.V., Nīderlande
|
QH02AB06
|
dogs; cats
|
Vairāk
|
Medicinal product information
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| V/DCP/15/0025-01 |
20 mg |
1 |
Al/PE blisteris, 10 tablete |
-
|
| V/DCP/15/0025-02 |
20 mg |
2 |
Al/PE blisteris, 10 tablete |
-
|
| V/DCP/15/0025-03 |
20 mg |
3 |
Al/PE blisteris, 10 tablete |
-
|
| V/DCP/15/0025-04 |
20 mg |
4 |
Al/PE blisteris, 10 tablete |
-
|
| V/DCP/15/0025-05 |
20 mg |
5 |
Al/PE blisteris, 10 tablete |
-
|
| V/DCP/15/0025-06 |
20 mg |
6 |
Al/PE blisteris, 10 tablete |
-
|
| V/DCP/15/0025-07 |
20 mg |
7 |
Al/PE blisteris, 10 tablete |
-
|
| V/DCP/15/0025-08 |
20 mg |
8 |
Al/PE blisteris, 10 tablete |
-
|
| V/DCP/15/0025-09 |
20 mg |
9 |
Al/PE blisteris, 10 tablete |
-
|
| V/DCP/15/0025-10 |
20 mg |
10 |
Al/PE blisteris, 10 tablete |
-
|
| V/DCP/15/0025-11 |
20 mg |
15 |
Al/PE blisteris, 10 tablete |
-
|
| V/DCP/15/0025-12 |
20 mg |
25 |
Al/PE blisteris, 10 tablete |
-
|
| V/DCP/15/0025-13 |
20 mg |
50 |
Al/PE blisteris, 10 tablete |
-
|
|
|
Prednicortone vet
|
5 mg
|
V/DCP/15/0024
|
Dechra Regulatory B.V., Nīderlande
|
QH02AB06
|
dogs; cats
|
Vairāk
|
Medicinal product information
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| V/DCP/15/0024-01 |
5 mg |
1 |
PVH/PVdH/Al blisteris, 10 tablete |
-
|
| V/DCP/15/0024-02 |
5 mg |
2 |
PVH/PVdH/Al blisteris, 10 tablete |
-
|
| V/DCP/15/0024-03 |
5 mg |
3 |
PVH/PVdH/Al blisteris, 10 tablete |
-
|
| V/DCP/15/0024-04 |
5 mg |
4 |
PVH/PVdH/Al blisteris, 10 tablete |
-
|
| V/DCP/15/0024-05 |
5 mg |
5 |
PVH/PVdH/Al blisteris, 10 tablete |
-
|
| V/DCP/15/0024-06 |
5 mg |
6 |
PVH/PVdH/Al blisteris, 10 tablete |
-
|
| V/DCP/15/0024-07 |
5 mg |
7 |
PVH/PVdH/Al blisteris, 10 tablete |
-
|
| V/DCP/15/0024-08 |
5 mg |
8 |
PVH/PVdH/Al blisteris, 10 tablete |
-
|
| V/DCP/15/0024-09 |
5 mg |
9 |
PVH/PVdH/Al blisteris, 10 tablete |
-
|
| V/DCP/15/0024-10 |
5 mg |
10 |
PVH/PVdH/Al blisteris, 10 tablete |
-
|
| V/DCP/15/0024-11 |
5 mg |
15 |
PVH/PVdH/Al blisteris, 10 tablete |
-
|
| V/DCP/15/0024-12 |
5 mg |
25 |
PVH/PVdH/Al blisteris, 10 tablete |
-
|
| V/DCP/15/0024-13 |
5 mg |
50 |
PVH/PVdH/Al blisteris, 10 tablete |
-
|
|
|
Clindacutin
|
10 mg/g
|
V/DCP/21/0008
|
Dechra Regulatory B.V., Nīderlande
|
QD06AX
|
dogs
|
Vairāk
|
Medicinal product information
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| V/DCP/21/0008-01 |
10 mg/g |
1 |
Alumīnija tūbiņa, 20 g |
-
|
|
|
Amoxyvet
|
697 mg/g
|
V/DCP/22/0035
|
Huvepharma NV, Beļģija
|
QJ01CA04
|
pigs; chickens
|
Vairāk
|
Medicinal product information
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| V/DCP/22/0035-01 |
697 mg/g |
1 |
Burciņa, 100 g |
-
|
| V/DCP/22/0035-02 |
697 mg/g |
1 |
Polietilēna maiss, 100 g |
-
|
| V/DCP/22/0035-03 |
697 mg/g |
1 |
Polietilēna maiss, 500 g |
-
|
| V/DCP/22/0035-04 |
697 mg/g |
1 |
Polietilēna maiss, 1 kg |
-
|
|
|
Dozuril
|
25 mg/ml
|
V/DCP/12/0036
|
Dopharma Research B.V., Nīderlande
|
QP51AJ01
|
chickens
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
solution for use in drinking water
|
| International name (active substance): |
Toltrazuril
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
Laboratorios Calier, S.A., Spānija
|
| Date of authorisation/renewal: |
04-Jul-2017
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
DCP
|
| Package leaflet: |
[DOC] 200421MLI (20-Apr-2021)
|
| Labelling text: |
[DOC] 200421MLI (20-Apr-2021)
|
| Summary of product characteristics: |
[DOC] 200421ZA (20-Apr-2021)
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| V/DCP/12/0036-01 |
25 mg/ml |
1 |
Polietilēna pudelīte, 1 l |
-
|
| V/DCP/12/0036-02 |
25 mg/ml |
1 |
Polietilēna pudelīte, 5 l |
-
|
|
|
Parofor crypto
|
140000 IU/ml
|
V/DCP/19/0046
|
Huvepharma NV, Beļģija
|
QA07AA06
|
sheep; goats
|
Vairāk
|
Medicinal product information
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| V/DCP/19/0046-01 |
140000 IU/ml |
1 |
ABPE pudele, 125 ml |
-
|
| V/DCP/19/0046-02 |
140000 IU/ml |
1 |
ABPE pudele, 250 ml |
-
|
| V/DCP/19/0046-03 |
140000 IU/ml |
1 |
ABPE pudele, 500 ml |
-
|
| V/DCP/19/0046-04 |
140000 IU/ml |
1 |
ABPE pudele, 1 l |
-
|
|
|
Huvecin
|
25 mg/ml
|
V/DCP/22/0047
|
Huvepharma NV, Beļģija
|
QJ01FA94
|
pigs
|
Vairāk
|
Medicinal product information
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| V/DCP/22/0047-01 |
25 mg/ml |
1 |
Stikla pudele, 50 ml |
-
|
| V/DCP/22/0047-02 |
25 mg/ml |
1 |
Stikla pudele, 100 ml |
-
|
| V/DCP/22/0047-03 |
25 mg/ml |
1 |
Stikla pudele, 250 ml |
-
|
|
|
Huvecin
|
100 mg/ml
|
V/DCP/22/0048
|
Huvepharma NV, Beļģija
|
QJ01FA94
|
cattle; pigs; sheep
|
Vairāk
|
Medicinal product information
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| V/DCP/22/0048-01 |
100 mg/ml |
1 |
Stikla pudele, 20 ml |
-
|
| V/DCP/22/0048-02 |
100 mg/ml |
1 |
Stikla pudele, 50 ml |
-
|
| V/DCP/22/0048-03 |
100 mg/ml |
1 |
Stikla pudele, 100 ml |
-
|
| V/DCP/22/0048-04 |
100 mg/ml |
1 |
Stikla pudele, 250 ml |
-
|
|
|
Cefabactin vet
|
50 mg
|
V/DCP/16/0015
|
Le Vet Beheer B.V., Nīderlande
|
QJ01DB01
|
dogs; cats
|
Vairāk
|
Medicinal product information
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| V/DCP/16/0015-01 |
50 mg |
1 |
PVDH/PE/PVH/Al blisteris, 10 tablete |
-
|
| V/DCP/16/0015-02 |
50 mg |
2 |
PVDH/PE/PVH/Al blisteris, 10 tablete |
-
|
| V/DCP/16/0015-03 |
50 mg |
3 |
PVDH/PE/PVH/Al blisteris, 10 tablete |
-
|
| V/DCP/16/0015-04 |
50 mg |
4 |
PVDH/PE/PVH/Al blisteris, 10 tablete |
-
|
| V/DCP/16/0015-05 |
50 mg |
5 |
PVDH/PE/PVH/Al blisteris, 10 tablete |
-
|
| V/DCP/16/0015-06 |
50 mg |
6 |
PVDH/PE/PVH/Al blisteris, 10 tablete |
-
|
| V/DCP/16/0015-07 |
50 mg |
7 |
PVDH/PE/PVH/Al blisteris, 10 tablete |
-
|
| V/DCP/16/0015-08 |
50 mg |
8 |
PVDH/PE/PVH/Al blisteris, 10 tablete |
-
|
| V/DCP/16/0015-09 |
50 mg |
9 |
PVDH/PE/PVH/Al blisteris, 10 tablete |
-
|
| V/DCP/16/0015-10 |
50 mg |
10 |
PVDH/PE/PVH/Al blisteris, 10 tablete |
-
|
| V/DCP/16/0015-11 |
50 mg |
25 |
PVDH/PE/PVH/Al blisteris, 10 tablete |
-
|
| V/DCP/16/0015-12 |
50 mg |
10 |
Kastīte ar blisteri, 10 tablete |
-
|
|
|
Cefabactin vet
|
250 mg
|
V/DCP/16/0016
|
Le Vet Beheer B.V., Nīderlande
|
QJ01DB01
|
dogs; cats
|
Vairāk
|
Medicinal product information
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| V/DCP/16/0016-01 |
250 mg |
1 |
PVDH/PE/PVH/Al blisteris, 10 tablete |
-
|
| V/DCP/16/0016-02 |
250 mg |
2 |
PVDH/PE/PVH/Al blisteris, 10 tablete |
-
|
| V/DCP/16/0016-03 |
250 mg |
3 |
PVDH/PE/PVH/Al blisteris, 10 tablete |
-
|
| V/DCP/16/0016-04 |
250 mg |
4 |
PVDH/PE/PVH/Al blisteris, 10 tablete |
-
|
| V/DCP/16/0016-05 |
250 mg |
5 |
PVDH/PE/PVH/Al blisteris, 10 tablete |
-
|
| V/DCP/16/0016-06 |
250 mg |
6 |
PVDH/PE/PVH/Al blisteris, 10 tablete |
-
|
| V/DCP/16/0016-07 |
250 mg |
7 |
PVDH/PE/PVH/Al blisteris, 10 tablete |
-
|
| V/DCP/16/0016-08 |
250 mg |
8 |
PVDH/PE/PVH/Al blisteris, 10 tablete |
-
|
| V/DCP/16/0016-09 |
250 mg |
9 |
PVDH/PE/PVH/Al blisteris, 10 tablete |
-
|
| V/DCP/16/0016-10 |
250 mg |
10 |
PVDH/PE/PVH/Al blisteris, 10 tablete |
-
|
| V/DCP/16/0016-11 |
250 mg |
25 |
PVDH/PE/PVH/Al blisteris, 10 tablete |
-
|
| V/DCP/16/0016-12 |
250 mg |
10 |
Kastīte ar blisteri, 10 tablete |
-
|
|
|
Pigfen
|
40 mg/g
|
V/DCP/16/0035
|
Huvepharma NV, Beļģija
|
QP52AC13
|
pigs
|
Vairāk
|
Medicinal product information
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| V/DCP/16/0035-01 |
40 mg/g |
1 |
Polietilēna maiss, 1 kg |
-
|
| V/DCP/16/0035-02 |
40 mg/g |
1 |
Polietilēna maiss, 2 kg |
-
|
| V/DCP/16/0035-03 |
40 mg/g |
1 |
Polietilēna maiss, 5 kg |
-
|
| V/DCP/16/0035-04 |
40 mg/g |
1 |
Polietilēna maiss, 20 kg |
-
|
|
|
Hydrotrim
|
500 mg/g
|
V/DCP/23/0050
|
Huvepharma NV, Beļģija
|
QJ01EW10
|
pigs; sheep; chickens; pre-ruminant cattle
|
Vairāk
|
Medicinal product information
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| V/DCP/23/0050-01 |
|
1 |
Papīra/PE/Al folijas/PE paciņa, 100 g |
-
|
| V/DCP/23/0050-02 |
|
1 |
Papīra/PE/Al folijas/PE paciņa, 1 kg |
-
|
|
|
Spotinor
|
10 mg/ml
|
V/DCP/14/0048
|
Norbrook Laboratories (Ireland) Limited, Īrija
|
QP53AC11
|
cattle; sheep
|
Vairāk
|
Medicinal product information
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| V/DCP/14/0048-01 |
10 mg/ml |
1 |
ABPE pudele, 250 ml |
-
|
| V/DCP/14/0048-02 |
10 mg/ml |
1 |
ABPE pudele, 500 ml |
-
|
| V/DCP/14/0048-03 |
10 mg/ml |
1 |
ABPE mugursomas tipa konteiners (balts), 1 l |
-
|
| V/DCP/14/0048-04 |
10 mg/ml |
1 |
ABPE mugursomas tipa konteiners (balts), 2,5 l |
-
|
| V/DCP/14/0048-05 |
10 mg/ml |
2 |
ABPE pudele, 500 ml |
-
|
|
|
Canishield
|
0.77 g
|
V/DCP/18/0038
|
Beaphar B.V., Nīderlande
|
QP53AC11
|
medium dogs; small dogs
|
Vairāk
|
Medicinal product information
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| V/DCP/18/0038-01 |
|
1 |
Paciņa, 1 deva |
-
|
| V/DCP/18/0038-02 |
|
2 |
Paciņa, 1 deva |
-
|
|
|
Canishield
|
1.04 g
|
V/DCP/18/0039
|
Beaphar B.V., Nīderlande
|
QP53AC11
|
large dogs
|
Vairāk
|
Medicinal product information
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| V/DCP/18/0039-01 |
|
1 |
Paciņa, 1 deva |
-
|
| V/DCP/18/0039-02 |
|
2 |
Paciņa, 1 deva |
-
|
|